ABCL-452 First-Line Treatment With Subcutaneous Epcoritamab + R-CHOP in Patients With High-Risk Diffuse Large B-Cell Lymphoma (DLBCL): Phase 1/2 Data Update
- Resource Type
- Source
- Clinical Lymphoma Myeloma and Leukemia. 22:S380
- Subject
Cancer Research Oncology Hematology - Language
- ISSN
- 2152-2650